Asian Journal of Medical Principles and Clinical Practice

Community-Acquired Pneumonia in Pediatric Patients

Maha Saied Ahmed Eldohemy *

Danat Al Emarat Hospital, United Arab Emirates.

*Author to whom correspondence should be addressed.

---

Abstract

Community-acquired pneumonia (CAP) remains a significant cause of morbidity and mortality in pediatric patients worldwide. Epidemiological studies reveal variations in the incidence and prevalence of CAP among different age groups, geographic locations, and socioeconomic backgrounds. Various pathogens, including bacteria, viruses, and atypical organisms, contribute to the development of CAP in children, with Streptococcus pneumoniae being the most common bacterial cause. Clinical presentation can range from mild respiratory symptoms to severe respiratory distress, necessitating hospitalization and intensive care. Diagnosis relies on a combination of clinical assessment, radiological findings, and microbiological tests, although challenges persist in distinguishing viral from bacterial etiologies. Management involves appropriate antimicrobial therapy, supportive care, and consideration of vaccination status. However, rising antimicrobial resistance poses challenges in treatment selection, emphasizing the importance of reasonable antibiotic use. Prevention strategies, including vaccination against common pathogens and promotion of hygiene measures, play a crucial role in reducing the burden of CAP in pediatric populations. Overall, a multidisciplinary approach involving pediatricians, infectious disease specialists, radiologists, and public health officials is essential for effectively managing and preventing CAP in children. Further research is needed to address emerging pathogens, optimize diagnostic strategies, and refine treatment guidelines to improve outcomes in pediatric patients with CAP. This abstract provides a comprehensive review of the epidemiology, etiology, clinical presentation, diagnosis, management, and prevention strategies related to CAP in children. It will help understand the ever-changing trends in the field of child-care that come with the prevalence of pneumonia in pediatric patients.

Keywords: Pneumonia, pediatric patients, community-acquired, respiratory infections, treatment of pneumonia

---

---

---

References

Rodrigues CMC, Groves H. Community-Acquired Pneumonia in Children: The challenges of microbiological diagnosis. J Clin Microbiol. 2018;56(3):e01318-17.

Davies HD. Community-acquired pneumonia in children. Paediatr Child Health. 2003;8(10):616–9.

Katz SE, Williams DJ. Pediatric community-acquired pneumonia in the United States. Infect Dis Clin North Am. 2018;32(1):47–63.

Leung AKC, Wong AHC, Hon KL. Community-acquired pneumonia in children. Recent Pat Inflamm Allergy Drug Discov. 2018;12(2):136–44.

Nascimento-Carvalho CM. Community-acquired pneumonia among children: The latest evidence for an updated management. J Pediatr (Rio J). 2019; 96(Suppl 1):29–38.

Smith DK, Kuckel DP, Recidoro AM. Community-acquired pneumonia in children: Rapid evidence review. Am Fam Physician. 2021;104(6):618–25.

Tramper-Stranders GA. Childhood community-acquired pneumonia: A review of etiology- and antimicrobial treatment studies. Paediatr Respir Rev. 2018;26:41–8.

Alzomor O, Alhajjar S, Aljobair F, Alenizi A, Alodyani A, Alzahrani M, et al. Management of community-acquired pneumonia in infants and children: Clinical practice guidelines endorsed by the Saudi Pediatric Infectious Diseases Society. Int J Pediatr Adolesc Med. 2017;4(4):153–8.

Nascimento-Carvalho AC, Nascimento-Carvalho CM. Clinical management of community-acquired pneumonia in young children. Expert Opin Pharmacother. 2019;20(4):435–42.

Singla S, Sih K, Goldman RD. Antibiotic treatment duration for community-acquired pneumonia in children. Can Fam Physician. 2023;69(6):400.

Mi X, Li W, Zhang L, Li J, Zeng L, Huang L, et al. The drug use to treat community-acquired pneumonia in children. Medicine (Baltimore). 2018;97(46):e13224.

Cardinale F, Cappiello AR, Mastrototaro MF, Pignatelli M, Esposito S. Community-acquired pneumonia in children. Early Hum Dev. 2013;89:S49–52.

Qian C, Chen Q, Lin W, Li Z, Zhu J, Zhang J, et al. Incidence of community-acquired pneumonia among children under 5 years in Suzhou, China: a hospital-based cohort study. BMJ Open. 2024;14(1): e078489.

Manikam L, Lakhanpaul M. Epidemiology of community acquired pneumonia. Paediatr Child Health. 2012;22(7):299–306.

Lokida D, Farida H, Triasih R, Mardian Y, Kosasih H, Naysilla AM, et al. Epidemiology of community-acquired pneumonia among hospitalised children in Indonesia: a multicentre, prospective study. BMJ Open. 2022; 12(6):e057957.

Takeuchi N, Naito S, Ohkusu M, Abe K, Shizuno K, Takahashi Y, et al. Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan. Epidemiol Infect. 2020;148:e91.

Gowraiah V, Awasthi S, Kapoor R, Sahana D, Venkatesh P, Gangadhar B, et al. Can we distinguish pneumonia from wheezy diseases in tachypnoeic children under low-resource conditions? A prospective observational study in four Indian hospitals. Arch Dis Child. 2014;99(10): 899–906.

Østergaard MS, Nantanda R, Tumwine JK, Aabenhus R. Childhood asthma in low income countries: An invisible killer? Prim Care Respir J J Gen Pract Airw Group. 2012;21(2):214–9.

Revised WHO classification and treatment of pneumonia in children at health facilities: Evidence summaries. Geneva: World Health Organization (WHO Guidelines Approved by the Guidelines Review Committee); 2014. Available:http://www.ncbi.nlm.nih.gov/books/NBK264162/

Executive summary. In: Revised WHO classification and treatment of pneumonia in children at health facilities: Evidence summaries. World Health Organization; 2014. Available:https://www.ncbi.nlm.nih.gov/books/NBK264164/

Zar HJ, Moore DP, Andronikou S, Argent AC, Avenant T, Cohen C, et al. Diagnosis and management of community-acquired pneumonia in children: South African Thoracic Society guidelines. Afr J Thorac Crit Care Med. 2020;26(3). DOI:10.7196/AJTCCM.2020.v26i3.104.

Scientific basis of WHO recommendations for treatment of pneumonia. In: Revised WHO classification and treatment of pneumonia in children at health facilities: Evidence Summaries. World Health Organization; 2014. Available:https://www.ncbi.nlm.nih.gov/books/NBK264159/

Posten S, Reed J. Pediatric Community Acquired Pneumonia. S D Med J S D State Med Assoc. 2017;70(12):557–61.

Stuckey-Schrock K, Hayes BL, George CM. Community-acquired pneumonia in children. Am Fam Physician. 2012;86(7):6 61–7.

Kevat PM, Morpeth M, Graham H, Gray AZ. A systematic review of the clinical features of pneumonia in children aged 5-9 years: Implications for guidelines and research. J Glob Health. 2022;12: 10002.

Ebeledike C, Ahmad T, Martin SD. Pediatric Pneumonia (Nursing). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Available:http://www.ncbi.nlm.nih.gov/books/NBK568682/

Macpherson L, Ogero M, Akech S, Aluvaala J, Gathara D, Irimu G, et al. Risk factors for death among children aged 5–14 years hospitalised with pneumonia: a retrospective cohort study in Kenya. BMJ Glob Health. 2019;4(5):e001715.

McCollum ED, Ginsburg AS. Outpatient management of children with world health organization chest indrawing pneumonia: Implementation risks and proposed solutions. Clin Infect Dis Off Publ Infect Dis Soc Am. 2017;65(9):1560–4.

Jroundi I, Mahraoui C, Benmessaoud R, Moraleda C, Tligui H, Seffar M, et al. Risk factors for a poor outcome among children admitted with clinically severe pneumonia to a university hospital in Rabat, Morocco. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2014;28:164–70.

Principi N, Esposito S, Blasi F, Allegra L, Mowgli study group. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001;32 (9):1281–9.

Kumar S. Mycoplasma pneumoniae: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections. Indian J Med Res. 2018;147(1):23–31.

Schalock PC, Dinulos JGH. Mycoplasma pneumoniae-induced cutaneous disease. Int J Dermatol. 2009;48(7):673–80; quiz 680–1.

Rodrigues CM, Groves H. Community-acquired pneumonia in children: the challenges of microbiological diagnosis. Journal of Clinical Microbiology. 2018; 56(3):10-128.

Lanao AE, Chakraborty RK, Pearson-Shaver AL. Mycoplasma infections. In: StatPearls Treasure Island (FL): Stat Pearls Publishing; 2024 Available:http://www.ncbi.nlm.nih.gov/books/NBK536927/